HUBB vs OLMA · P/E 28, rev $5.84B vs $824.6M cap
Hubbell Inc (HUBB) versus Olema Pharmaceuticals Inc (OLMA) — a side-by-side from cached financials, not a winner call.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
Olema Pharmaceuticals Inc (OLMA) is a biotechnology company listed on NASDAQ.
Latest reported HUBB revenue for 2025-12-31 was $5.84B. Net income was $887.1M. Revenue was up 3.8% from 2024-12-31 to 2025-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
OLMA does not have a complete income-statement cache yet.
HUBB currently screens at market cap $22.14B and trailing P/E 28.0. OLMA currently screens at market cap $824.6M.
Not investment advice. Open the HUBB and OLMA stock pages for the full models.
Not investment advice.